期刊論文| 1. | The UK Prospective Diabetes Study Group(1998)。Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)。Lancet，352(9131)，854-865。   |
| 2. | King, H.、Aubert, R. E.、Herman, W. H.(1998)。Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections。Diabetes Care，21(9)，1414-1431。 |
| 3. | Diabetes Control and Complications Trial Research Group(1993)。The effect of intensive treatment of diabetes on the development and progression of long-term complications in insuHn dependent diabetes mellitus。N Engl J Med，329，977-986。 |
| 4. | UK Prospective Diabetes Study Group(1993)。Intensive blood-glucose control with sulfonylureas in patients with type 2 diabetes。Lancet，352，837-853。 |
| 5. | American Diabetes Association(2004)。Dyslipidemia management in adults with diabetes (Position Statement)。Diabetes Care，27(Suppl. 1)，68-71。 |
| 6. | Haffner, S. M.(1998)。Management of dyslipidemia in adults with diabetes (Technical review)。Diabetes Care，21，160-178。 |
| 7. | Chiang, C. W.、Chiu, H. F.、Chen, C. Y.、Wu, H. L.、Yang, C. Y.(2006)。Trends in the use of oral antidiabetic drugs by outpatients in Taiwan: 1997-2003。J Clin Pharm Ther，31，73-82。 |
| 8. | Skaer, T. L.、Sclar, D. A.、Robison, L. M.(2006)。Trends in the prescribing of oral agents for the management of type 2 diabetes mellitus in the United States, 1990-2001。Diabetes Educ，32，940-953。 |
| 9. | Garber, A. J.、Larsen, J.、Schneider, S. H.、Piper, B. A.、Henry, D.(2002)。Glyburide/metformin initial therapy study group. Simultaneous Glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes。Diabetes Obes Metab，4，201-208。 |
| 10. | Cohen, F. J.、Neslusan, C. A.、Conklin, J. E.、Song, X.(2003)。Recent antihyperglycemic prescribing trends for U.S. privately insured patients with type 2 diabetes。Diabetes Care，26，1847-1851。 |
| 11. | Tseng, F. Y.、Lai, M. S.(2006)。Effect of physician specialty on use of antidiabetes drugs, process and outcomes of diabetes care in a medical center。J Formos Med Assoc，105，821-831。 |
| 12. | Berardis, G. D.、Pelleggrini, F.、Franciosi, M.、Belfiglio, M.、Nardo, B. D.、Greenfield, S.、Kaplan, S. H.(2004)。Quality of care and outcomes in type 2 diabetic patients. A comparison between general practice and diabetes clinics。Diabetes Care，27，398-406。 |
| 13. | Nathan, D. M.、Buse, J. B.、Davidson, M. B.(2006)。Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: A consensus statement, from the American Diabetes Association and the European Association for the Study of Diabetes。Diabetologia，49，1711-1721。 |
| 14. | Nissen, S. E.、Wolski, K.(2007)。Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes。N Engl J Med，356(24)，2457-2471。 |
| 15. | Psaty, B. M.、Furberg, C. D.(2007)。Rosiglitazone and Cardiovascular Risk。Editorial) N Engl J Med，356，2522。 |
| 16. | Home, P. D.、Pocock, S. J.、Beck-Nielsen, H.(2007)。Rosiglitazone evaluated for cardiac outcomes--an interim analysis。N Engl J Med，357，28-38。 |
| 17. | Rothman, R. L.、DeWalt, D. A.、Malone, R.(2004)。Influence of Patient Literacy on the Effectiveness of a Primary Care-Based Diabetes Disease Management Program。JAMA，1711-1716。 |
| 18. | Drazen, J. M.、Morrissey, S.、Curfman, G. D.(2007)。Rosiglitazone--Continued Uncertainty about Safety。(Editorial) N Engl J Med，357，63。 |
| 19. | Dormandy, J. A.、Charbonnel, B.、Eckland, D. J.(2005)。Secondary prevention of macro vascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial。Lancet，366，1279-1289。 |
| 20. | Rothman, R. L.、Malone, R.、Bryant, B.(2005)。A randomized trial of a primary Patients care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes。Am J Med，118，276-284。 |
| 21. | Choe, H. M.、Mitrovich, S.、Dubay, D.(2005)。Proactive Case Management of High risk Patients with Type 2 Diabetes Mellitus by a Clinical Pharmacist: A Randomized Controlled Trial。Am J Manag Care，11，253-260。 |
| 22. | Tadros, L.、Ledger-Scott, M.、Stead, D.(2003)。The Pharmacist-led diabetic clinic improves glycaemic control in insulin-requiring type 2 diabetic patients: a randomized study。Int J Pharm Pract，11，14。 |
| 23. | Tadros, L.、Ledger-Scott, M.、Barnes, E.(2002)。The benefits of a pharmacist-led type 2 diabetes clinic。Hosp Pharm，9，204-206。 |
| 24. | Lee, V.、Leung, P. Y.(2003)。Glycemic control and medication compliance in diabetic patients in a pharmacist-managed clinic in Hong Kong。Am J Health-Syst Pharm，60，2593-2596。 |
| 25. | Lin, T.、Chou, P.、Lai, M. S.、Tsai, S. T.、Tai, T. Y.(2001)。Direct Cost of Illness of Patients with Diabetes Mellitus in Taiwan。Diabetes Research and Clinical Practice，54(suppl.)，s43-s46。 |
| 26. | American Diabetes Association.(2007)。Standards of Medical Care in Diabetes-2007。Diabetes Care，30(Supple 1)，S4-S41。 |
| 27. | Zimmet, P.、Alberti, K.、Shaw, J.(2001)。Global and societal implications of the diabetes epidemic。Nature，414(6865)，782-787。 |